STOCK TITAN

Heron Therapeutics COO converts 31,250 stock units

The chief operating officer's report includes both a restricted-stock-unit conversion and shares delivered or withheld for exercise-price or tax-liability payment.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Heron Therapeutics, Inc. reported that Chief Operating Officer Mark Earl Hensley converted 31,250 restricted stock units into 31,250 common shares on November 6, 2026. The report also lists 8,889 shares delivered or withheld for payment of exercise price or tax liability, with a reported price of $0.29 per share. Following the transaction, the report lists 312,500 directly held restricted stock units. Each unit represents a contingent right to one common share; the units vest 25% on the first anniversary of the May 6, 2025 grant date and then in 12 equal quarterly installments.

Insider Hensley Mark Earl
Role Chief Operating Officer
Type Security Shares Price Value
Exercise Restricted Stock Units F2 31,250 $0.00 $0.00
Exercise Common Stock F1 31,250 -- --
Exercise Price or Tax Liability Common Stock 8,889 $0.29 $3K
Holdings After Transaction: Restricted Stock Units — 312,500 units (Direct); Common Stock — 201,683 shares (Direct)
Holdings Before and After: Restricted Stock Units, 343,750 to 312,500 units (Direct); Common Stock, 179,322 to 201,683 shares (Direct)
Footnotes (2)
  1. F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
  2. F2. The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter.
Restricted stock units converted 31,250 units November 6, 2026
Common shares acquired through conversion 31,250 shares November 6, 2026
Shares delivered or withheld for exercise price or tax liability 8,889 shares November 6, 2026
Reported price per share for shares delivered or withheld $0.29 per share November 6, 2026 transaction
Restricted stock units following transaction 312,500 units Directly held
Initial vesting 25% On the first anniversary of the May 6, 2025 grant date
Subsequent vesting installments 12 equal quarterly installments After the initial vesting
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"a contingent right to receive one share of common stock"
quarterly installments financial
"twelve (12) equal quarterly installments thereafter"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What HRTX stock transactions did Mark Earl Hensley report on November 6, 2026?

Mark Earl Hensley reported converting 31,250 restricted stock units into 31,250 common shares. The report also lists 8,889 shares delivered or withheld for payment of exercise price or tax liability, with a reported price of $0.29 per share.

How do Mark Earl Hensley's HRTX restricted stock units vest?

The restricted stock units vest 25% on the first anniversary of the May 6, 2025 grant date, followed by 12 equal quarterly installments. Each unit represents a contingent right to receive one common share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hensley Mark Earl

(Last)(First)(Middle)
25 FENTON MAIN STREET
SUITE 300

(Street)
CARY NORTH CAROLINA 27511

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HERON THERAPEUTICS, INC. /DE/ [ HRTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/06/2026M31,250A(1)210,572D
Common Stock11/06/2026F8,889D$0.29201,683D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$011/06/2026M31,250 (2) (2)Common Stock31,250$0312,500D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of common stock.
2. The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter.
/s/Kathryn Lester Attorney-in-fact for Mark E. Hensley11/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading